Article

Decentration/dislocation one of the most common reasons for foldable IOL explantation

One of the most common reasons for foldable IOL explantation seems to be decentration/dislocation in one- and three-piece silicone and acrylic lenses, followed by glare and optical aberrations, explained Nick Mamalis, MD, professor of ophthalmology, Intermountain Ocular Research Center, John A. Moran Eye Center, University of Utah, Salt Lake City.

One of the most common reasons for foldable IOL explantation seems to be decentration/dislocation in one- and three-piece silicone and acrylic lenses, followed by glare and optical aberrations, explained Nick Mamalis, MD, professor of ophthalmology, Intermountain Ocular Research Center, John A. Moran Eye Center, University of Utah, Salt Lake City.

Removal of hydrophilic acrylic IOLs was most commonly attributed to calcification/opacification, Dr. Mamalis said. He reported on the 2006 results of a survey sent to members of the American Society of Cataract and Refractive Surgery and the European Society of Cataract and Refractive Surgeons.

"The most common complications involving foldable IOLs have changed little over the past 3 years," Dr. Mamalis said.

Apparently, incorrect lens power is not as much of a concern as it had been in the past, he said. Surgeons are better able to determine the correct lens power prior to surgery and/or corneal enhancement procedures have been utilized in patients with residual refractive error.

"Common complications [with foldable lenses] may continue to be avoided by excellent surgical technique, quality manufacturing, careful IOL folding and insertion, and accurate IOL measurements," Dr. Mamalis said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
© 2025 MJH Life Sciences

All rights reserved.